Back

Ablation is alternative to ICD therapy post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: pro

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Controversies in ventricular tachycardia ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Philippe Maury

Rangueil Hospital of Toulouse, Toulouse (France)

5 More presentations in this session

Presentation thumbnail
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: pro
Professor T. Deneke (Nuremberg, DE)
Slides Video
Presentation thumbnail
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: con
Professor C. de Chillou (Nancy, FR)
Slides Video
Presentation thumbnail
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: discussion
Video
Presentation thumbnail
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
Doctor A. Wijnmaalen (Leiden, NL)
Slides Video
Presentation thumbnail
Ablation is alternative to ICD therapy post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT: discussion
Video

Access the full session

Session thumbnail
Controversies in ventricular tachycardia ablation
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: con
thumbnail
Congress Presentation
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: pro
thumbnail
Congress Presentation
Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources